Hyderabad’s position as vaccine capital bolstered: KTR

BioAsia’s Genome Valley Excellence Award presented to Bharat Biotech

Updated - February 23, 2021 11:40 am IST

Published - February 22, 2021 11:58 pm IST - Hyderabad

Telangana IT Minister K.T. Rama Rao presenting the Genome Valley Excellence award to CMD of Bharat Biotech Krishna Ella and joint MD Suchitra K. Ella in Hyderabad.

Telangana IT Minister K.T. Rama Rao presenting the Genome Valley Excellence award to CMD of Bharat Biotech Krishna Ella and joint MD Suchitra K. Ella in Hyderabad.

Telangana Industries and IT Minister K.T.Rama Rao on Monday said the dream and vision of growing the life sciences sector to over $100 billion looks plausible.

“We remain committed,” he said, seeking to highlight how the sector in Telangana responded with resilience and witnessed tremendous growth amid the COVID-19 pandemic. The sector, in the State, attracted about ₹3,700 crore investments in the last one year with an employment potential for around 14,000 people, he told the inaugural session of BioAsia 2021.

Moment in spotlight

According to the Minister, with scientists and entrepreneurs giving the sector its moment in the spotlight by accelerating development of vaccines, diagnostics and therapeutics Hyderabad’s life sciences ecosystem came to the fore and displayed fortitude.

“I take pride in saying Hyderabad rose to the occasion… our position as the vaccine capital of the world was bolstered and world is looking to India and Hyderabad,” he said.

Mr.Rao, who earlier presented BioAsia’s Genome Valley Excellence Award to Bharat Biotech, said the company’s “remarkable contribution and commitment to develop India’s first indigenous vaccine for COVID-19 [Covaxin]” as well as efforts of other vaccine makers Biological E and Indian Immunologicals are laudable.

Noting how Hetero Pharma and Dr.Reddy’s Laboratories were set to augment global supply by manufacturing and distributing Russian vaccine Sputnik and Aurobindo Pharma is setting up a vaccine manufacturing facility with a capacity of about 450 million doses, he said “all these highlight the position of Hyderabad as the vaccine capital… extremely confident significant global population will be immunised with vaccines produced in Hyderabad.”

Vision 2030

Chairman of Telangana Life Sciences Advisory Committee and pharma major Dr.Reddy’s Laboratories K.Satish Reddy told the gathering that the State sought to emerge as one of the top life sciences clusters in Asia by 2030. The vision was to contribute to the growth of the life sciences sector in Telangana from the existing around $13 billion to $50 billion in 10 years. There is potential to touch $100 billion, he said.

A report of the Committee last year had said to realise the $50 billion in cluster revenues vision (and $100 billion ecosystem valuation) in 10 years, the sector ought to grow around 15% as against the 12% at present.

Bharat Biotech founder and CMD Krishna Ella, who received the Genome Valley Excellence Award along with JMD Suchitra Ella, said the recognition is for all the entrepreneurs who contributed to the emergence of Hyderabad as a vaccine hub. Almost 65% of vaccines made in India come from Hyderabad.

On pandemic vaccines, he said “anything in future will also come only from Hyderabad… with new entrants, it is going to be bigger game for India and vaccines”.

This is the 18th edition of BioAsia and the two-day event devoted to life sciences is being organised by Telangana government.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.